AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H921-H928, 2006. First published February 3, 2006; doi:10.1152/ajpheart.00986.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/2/H921    most recent
00986.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guazzi, M.
Right arrow Articles by Guazzi, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guazzi, M.
Right arrow Articles by Guazzi, M. D.

Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion

Marco Guazzi,1 Sebastiano Belletti,1 Elisabetta Bianco,1 Laura Lenatti,1 and Maurizio D. Guazzi2

1Cardiopulmonary Unit, Cardiology Division, University of Milan, San Paolo Hospital; and 2Institute of Cardiology, University of Milan, Milan, Italy

Submitted 15 September 2005 ; accepted in final form 31 January 2006

Endothelial dysfunction and underperfusion of exercising muscle contribute to exercise intolerance, hyperventilation, and breathlessness in atrial fibrillation (AF). Cardioversion (CV) improves endothelial function and exercise performance. We examined whether CV is equally beneficial in diabetes and hypertension, diseases that cause endothelial dysfunction and are often associated with AF. Cardiopulmonary exercise and pulmonary and endothelial (brachial artery flow-mediated dilation) function were tested before and after CV in patients with AF alone (n = 18, group 1) or AF with hypertension (n = 19, group 2) or diabetes (n = 19, group 3). Compared with group 1, peak exercise workload, O2 consumption (VO2), O2 pulse, aerobic efficiency ({Delta}VO2/{Delta}WR), and ratio of brachial diameter changes to flow changes ({Delta}D/{Delta}F) were reduced in group 2 and, to a greater extent, in group 3; exercise ventilation efficiency (VE/VCO2 slope) and dead space-to-tidal volume ratio (VD/VT) were similar among groups. CV had less effect on peak workload (+7% vs. +18%), peak VO2 (+12% vs. +17%), O2 pulse (+33% vs. +50%), {Delta}VO2/{Delta}WR (+7% vs. +12%), VE/VCO2 slope (–6% vs. –12%), {Delta}D/{Delta}F (+7% vs. +10%), and breathlessness (Borg scale) in group 2 than in group 1 and was ineffective in group 3. The antioxidant vitamin C, tested in eight additional patients in each cohort, improved flow-mediated dilation in groups 1 and 2 before, but not after, CV and was ineffective in group 3, suggesting that the oxidative injury is least in lone AF, greater in hypertension with AF, and greater still in diabetes with AF. Comorbidities that impair endothelial activity worsen endothelial dysfunction and exercise intolerance in AF. The advantages of CV appear to be inversely related to the extent of the underlying oxidative injury.

arrhythmias; endothelium; exercise



Address for reprint requests and other correspondence: M. Guazzi, Cardiopulmonary Unit, Cardiology Div., Univ. of Milan, San Paolo Hospital, Via A. di Rudinì, 8, 20142 Milan, Italy (e-mail: marco.guazzi{at}unimi.it)




This article has been cited by other articles:


Home page
HeartHome page
M Guazzi and R Arena
Endothelial dysfunction and pathophysiological correlates in atrial fibrillation
Heart, January 15, 2009; 95(2): 102 - 106.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M. D. Guazzi
Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2136 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Guazzi, M. Berti, S. Belletti, G. Reina, and M. D. Guazzi
Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2396 - H2402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.